Search:
 
BioEnterprise
Recent News

» Clayton Dubilier & Goldman Sachs to Acquire Edgepark Medical for $850 Million
» Great Lakes Pharmaceuticals raises $3.1 Million
» AxioMed Raises $14.5 Million
» Syncro Raises Additional $800,000
» Factory Jobs Return, but Employers Find Skills Shortage
» Two Healthcare Companies Announce Major Expansions
» Ohioans vote for their futures, extend Third Frontier program



Commercialized Products & Services


Syncro Blue Tube
One of the many health care innovations brought to market by client companies.
» View More




Exit Companies



Since 2002, 21 Cleveland-area health care companies have had successful exits.

» View More




Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the health care industry.
» View More
Companies > Clinical
print
Athersys (ATHX) is a fully integrated pre-clinical, product discovery and development company with multiple synthetic pharmaceutical programs focused on obesity, cognition and other CNS disorders and asthma. The company also has a major effort in regenerative medicine (cell therapy). Using its MultiStem ™ platform (Multipotent Adult Progenitor Cells), the company has multiple programs focused on cardiovascular disease, neurology, hematological and immune disorders and a range of other indications.


Funders:
Radius Ventures, Orbimed, MPM, Hambrecht & Quist, A.M. Pappas Ventures, RA Capital Management, Accipiter Capital, Angiotech, Blue Chip, Invesco, Primus, Western Technology.
 
Copyright © 2010 BioEnterprise   | Home | Disclaimer | Sitemap | Contact Us BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999